Melanoma addiction to the long non-coding RNA SAMMSON. - PubMed - NCBI ncbi.nlm.nih.gov/m/pubmed/27008…

Symposium: PROZESSSCHRITTE OPTIMIEREN – NEUE POTENTIALE FÜR DIE BIOTECHNOLOGIE healthcapital.de/biotechnologie…

nature.com/articles/n-119…

Today we celebrate #WomenInScience because gender equality and women’s empowerment are pre-conditions 4 sustainable development

BioNukleo will present it's technology at german biotechnology days in Hannover, meet us at April 5 13:30 in Saal 1B biotechnologietage.de/de/

Interested in enzyme design? nature.com/articles/ncomm…

SOFINNOVA:The next big thing in biotech: immuno-oncology. We are providing new drugs to the market. #LBRefresh

The Impact Factor for Nucleic Acids Research has gone up! Check out content from the journal amf.so/151xg @NAR_Open

Yeeeah: DexLeChem CEO Sonja Jost was voted as one of the #25women who change the world" #GreenChemistry #BigBusiness

The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks zika virus replication sciencedirect.com/science/articl…

German article: Nukleosideanalogon Cladribin senkt die Schubrate bei MS Patienten- EU Zulassung pharmazeutische-zeitung.de/index.php?id=7…

European Commission Grants Approval for Mavenclad (Cladribine Tablets) finanznachrichten.de/nachrichten-20…

BioNukleo is a part of the Network for Pharma Solutions, Germany: bionukleo.com/news/

Long term study of patients with Hairy cell leukemia diagnosed between 1995 and 2013: clinical-lymphoma-myeloma-leukemia.com/action/showFul…

One step forward in the fight against multidrug resistant bacteria: cell.com/cell/fulltext/…

Exciting talks about new perspectives in medicine using AI and big data approaches at #futuremed17 #sciencematch

Great! Sonja Jost inspires young students for a startup career: ttps://www.morgenpost.de/212291559?__pwh=X9WkkAMKeYzBmjX48mQtfg==

Significant anti-tumor activity by E.coli PNPs and Gene Directed Prodrug Enzyme Therapy: ncbi.nlm.nih.gov/pubmed/29119917

This evening we will discuss with impressing femal founders about leading a company thanks@DexLeChem ALPHAZIRKEL - THE FAMILY ENTREPRENEUR NETWORK alphazirkel.de/Veranstaltung/…

New in J Biotechnol: Biocatalyst immobilization with more than 300 h stability and almost 3 months storage without activity loss: ncbi.nlm.nih.gov/pubmed/29355814